| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2007 | WO2007067757A2 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007067756A2 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007067752A2 Certain compositions and methods of treatment |
| 06/14/2007 | WO2007067727A2 Metronidazole cocrystals and imipramine cocrystals |
| 06/14/2007 | WO2007067714A2 Treatment of sequelae of psychiatric disorders |
| 06/14/2007 | WO2007067711A2 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007067710A1 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007067695A2 Dna methylation as a target for diagnosis and treatment of chronic lymphocytic leukemia (cll) |
| 06/14/2007 | WO2007067637A2 Cartilage repair methods |
| 06/14/2007 | WO2007067629A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | WO2007067625A2 Bioabsorbable surgical composition |
| 06/14/2007 | WO2007067623A2 Biocompatible tissue sealants and adhesives |
| 06/14/2007 | WO2007067622A2 Carbodiimide crosslinking of functionalized polethylene glycols |
| 06/14/2007 | WO2007067621A2 Biocompatible surgical compositions |
| 06/14/2007 | WO2007067619A2 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007067615A2 Thiadiazole derivatives as antidiabetic agents |
| 06/14/2007 | WO2007067614A1 l, l, 3-TRI0X0-l, 2, 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS |
| 06/14/2007 | WO2007067612A1 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| 06/14/2007 | WO2007067581A1 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
| 06/14/2007 | WO2007067570A1 Methods and compositions for the treatment of disease |
| 06/14/2007 | WO2007067567A2 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or free fatty acid flux |
| 06/14/2007 | WO2007067565A1 Process for the preparation of purified crystalline cci-779 |
| 06/14/2007 | WO2007067537A1 Pyrrolopyridine kinase inhibiting compounds |
| 06/14/2007 | WO2007067520A2 Lipid-based compositions of antiinfectives for treating pulmonary infections |
| 06/14/2007 | WO2007067519A2 The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions |
| 06/14/2007 | WO2007067516A2 Multiple myeloma |
| 06/14/2007 | WO2007067515A2 Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics |
| 06/14/2007 | WO2007067511A2 Morpholine carboxamide prokineticin receptor antagonists |
| 06/14/2007 | WO2007067508A2 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 06/14/2007 | WO2007067504A2 Lactam compounds and methods of using the same |
| 06/14/2007 | WO2007067498A1 Estrogen cancer therapy |
| 06/14/2007 | WO2007067490A1 POLYMORPHS OF ANDROGEN RECEPTOR MODULATOR - (N-3H-IMIDAZO [4 , 5-B] PYRIDIN-2-YL-METHYL) -2-FLUORO-4-METHYL-3-OXO-4-AZA-ANDROST- l-EN-17 . BETA . -CARBOXAMIDE |
| 06/14/2007 | WO2007067489A1 Quinolone m1 receptor positive allosteric modulators |
| 06/14/2007 | WO2007067478A2 P38 kinase inhibiting agents |
| 06/14/2007 | WO2007067477A1 Nitric oxide-releasing polymers |
| 06/14/2007 | WO2007067470A2 Benzimidazole non-aqueous compositions |
| 06/14/2007 | WO2007067444A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | WO2007067364A2 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 06/14/2007 | WO2007067341A2 Compositions and methods for increasing insulin sensitivity |
| 06/14/2007 | WO2007067333A2 Trioxane dimers having high anticancer and long-lasting antimalarial activities |
| 06/14/2007 | WO2007067331A1 Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
| 06/14/2007 | WO2007067281A2 Method for demethylating the 3'-dimethylamino group of erythromycin compounds |
| 06/14/2007 | WO2007067128A1 New process for the preparation of esomeprazole non-salt form |
| 06/14/2007 | WO2007067071A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | WO2007067053A1 Composition containing oligosaccharides for the treatment / prevention of infections |
| 06/14/2007 | WO2007067048A1 Treatment of barrett's esophagus |
| 06/14/2007 | WO2007067036A2 New use of carbonic anhydrase inhibitors |
| 06/14/2007 | WO2007067033A1 Composition containing oligosaccharides for the treatment/ prevention of infections |
| 06/14/2007 | WO2007067027A1 Pharmaceutical compositions containing combined antidiabetic substances for use in type 2 diabetes mellitus |
| 06/14/2007 | WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom |
| 06/14/2007 | WO2007066889A1 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/14/2007 | WO2007066805A1 Lincomycin derivative and antibacterial agent containing the same as active ingredient |
| 06/14/2007 | WO2007066781A1 Process for producing pharmaceutical composition containing drug-encapsulating polymer micelle using fluorine-containing organic solvent |
| 06/14/2007 | WO2007066773A1 Isohumulone compound clathrate and composition containing the same |
| 06/14/2007 | WO2007066744A1 Method of improving absorbability of epigallocatechin, food, drink and food/drink material using the same and method of producing the same |
| 06/14/2007 | WO2007066678A1 Therapeutic agent for corneal/conjuctival disease |
| 06/14/2007 | WO2007066642A1 Oral preparation for preventing or improving skin dryness |
| 06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
| 06/14/2007 | WO2007066557A1 Phosphine transition metal complex, method for producing same and antitumor agent containing same |
| 06/14/2007 | WO2007066458A1 Yeast for extraction of lipid-soluble component, method for producing the same, color-improving agent using the same and method for producing lipid-soluble component |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066371A1 Composition based on triethyl citrate for the prevention of enzymatic hydrolysis of triglycerides |
| 06/14/2007 | WO2007066355A1 Processes for the preparation and estimation of enriched calcitriol containing extracts from cestrum diurnum and compositions thereof |
| 06/14/2007 | WO2007066340A1 Viscosupplementation with algal polysaccharides in the treatment of arthritis |
| 06/14/2007 | WO2007066200A2 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/14/2007 | WO2007066181A2 Methods of preparing a vegf-r inhibitor |
| 06/14/2007 | WO2007066151A2 Topical compositions for treatment of respiratory disorders |
| 06/14/2007 | WO2007066148A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | WO2007066130A2 Veterinary composition against endoparasites |
| 06/14/2007 | WO2007066103A1 Pyrimidine derivatives as class i pi3k inhibitor |
| 06/14/2007 | WO2007066102A1 Pyrimidine derivatives |
| 06/14/2007 | WO2007066099A1 Pyrimidine derivatives |
| 06/14/2007 | WO2007066068A2 Calcium ion channel receptor antagonist |
| 06/14/2007 | WO2007066041A2 Skin depigmentation composition containing a naphthonic acid derivative |
| 06/14/2007 | WO2007066008A1 Use of a polysaccharide which is excreted by the vibrio dlabolicus species for the regeneration and protection of the periodontium |
| 06/14/2007 | WO2007065950A1 Method for enriching short-chain nucleic acids |
| 06/14/2007 | WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/14/2007 | WO2007065942A2 Bis-heterocyclic imidazolyl compounds |
| 06/14/2007 | WO2007065940A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| 06/14/2007 | WO2007065939A1 Substituted thiazole derivatives and their uses as tyrosine kinase inhibitors |
| 06/14/2007 | WO2007065924A1 Bicyclic hξteroyclic compounds as antiinflammatory agents |
| 06/14/2007 | WO2007065916A1 Isoquinoline derivatives |
| 06/14/2007 | WO2007065898A1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 06/14/2007 | WO2007065892A1 Novel diazabicyclic aryl derivatives and their medical use |
| 06/14/2007 | WO2007065888A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 06/14/2007 | WO2007065883A1 Antiviral azanucleoside derivatives |
| 06/14/2007 | WO2007065869A1 Labelled docetaxel |
| 06/14/2007 | WO2007065864A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 06/14/2007 | WO2007065829A1 Antiviral nucleosides |
| 06/14/2007 | WO2007065828A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | WO2007065821A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | WO2007065820A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | WO2007065726A1 11β-BENZALDOXIME DERIVATIVES OF D-HOMOOESTRA-4,9-DIEN-3-ONES |
| 06/14/2007 | WO2007065713A2 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders |
| 06/14/2007 | WO2007065690A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/14/2007 | WO2007065684A2 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 06/14/2007 | WO2007065683A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 06/14/2007 | WO2007065669A1 Biaryl compounds useful as agonists of the gpr38 receptor |
| 06/14/2007 | WO2007065664A2 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors |